Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLaird Regulatory News (LRD)

  • There is currently no data for LRD

Form 8.3 - Laird Plc

25 Apr 2018 13:42

Norges Bank - Form 8.3 - Laird Plc

Norges Bank - Form 8.3 - Laird Plc

PR Newswire

London, April 25

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Norges Bank
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeLaird PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosureDealing Disclosure 24/04/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”Yes Not Required

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:28.125p ordinary & ADR's
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:5,067,5871.04
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:5,067,5871.04

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
28.125p ordinary & ADR'sBuy16,306GBP 1.9573

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:25/04/2018
Contact name:Sai Aanandha Shankhar
Telephone number:+4724073134

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
30th Oct 20153:04 pmRNSBlocklisting Interim Review
29th Oct 20157:00 amRNSBoard Changes
29th Oct 20157:00 amRNSTrading Update
28th Aug 20152:43 pmRNSTotal Voting Rights
24th Aug 20156:12 pmRNSDirector/PDMR Shareholding
17th Aug 20155:02 pmRNSDirector/PDMR Shareholding
12th Aug 20152:57 pmRNSPurchase of Shares by Employee Benefit Trust
10th Aug 20151:59 pmRNSPurchase of Shares by Employee Benefit Trust
4th Aug 20152:06 pmRNSDirector/PDMR Shareholding
30th Jul 20157:00 amRNSHalf Yearly Report
2nd Jul 201510:18 amRNSShare Awards for new Chief Financial Officer
29th Jun 201510:00 amRNSDirectorate Change
22nd Jun 20156:00 pmRNSDirector/PDMR Shareholding
29th May 20153:20 pmRNSTotal Voting Rights
28th May 201510:19 amRNSDirector/PDMR Shareholding
15th May 20154:12 pmRNSDirector/PDMR Shareholding
13th May 20153:52 pmRNSPDMR Shareholding
12th May 20152:01 pmRNSDirector/PDMR Shareholding
8th May 20153:32 pmRNSResult of AGM
8th May 20157:00 amRNSTrading Update
1st May 20153:25 pmRNSBlocklisting Interim Review
29th Apr 201510:05 amRNSDirectorate Change
26th Mar 20155:15 pmRNSAnnual Report and Notice of 2015 AGM
11th Mar 20152:22 pmRNSHolding(s) in Company
9th Mar 201512:00 pmRNSReplacement Director/PDMR Shareholding
6th Mar 20153:13 pmRNSTotal Voting Rights Update
6th Mar 20153:06 pmRNSDirector/PDMR Shareholding
3rd Mar 20154:25 pmRNSPurchase of shares by Employee Benefit Trust
3rd Mar 20153:06 pmRNSDirector/PDMR Shareholding
3rd Mar 20157:00 amRNSFinal Results
29th Jan 20159:46 amRNSBoard Changes
9th Jan 201511:47 amRNSTotal Voting Rights Update
9th Jan 20157:00 amRNSTrading Update and Notice of Results
12th Dec 20147:00 amRNSNotice of Trading Update and Full Year Results
31st Oct 20141:42 pmRNSTotal Voting Rights
24th Oct 20146:39 pmRNSDirector/PDMR Shareholding
24th Oct 20146:35 pmRNSTotal Voting Rights
22nd Oct 20142:38 pmRNSReplacement Interim Management Statement
22nd Oct 20147:00 amRNSInterim Management Statement
2nd Oct 20141:03 pmRNSBlocklisting Interim Review
22nd Sep 20147:00 amRNSDirectorate Change
31st Jul 20145:35 pmRNSDirector/PDMR Shareholding
31st Jul 20147:00 amRNSHalf Yearly Report
19th Jun 20141:16 pmRNSHolding(s) in Company
27th May 20149:26 amRNSDirector/PDMR Shareholding
2nd May 20142:31 pmRNSAGM Statement
2nd May 20147:00 amRNSInterim Management Statement
24th Apr 20146:27 pmRNSHolding(s) in Company
15th Apr 20149:14 amRNSAcquisition
31st Mar 201412:04 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.